Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

December 1, 2024; Volume 65,Issue 12

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 6A;

Discussions with Leaders

  • You have access
    Oncologist, Business Leader, and Investor Arie S. Belldegrun Discusses a Career in Innovative Medical Entrepreneurship
    Arie S. Belldegrun, Ken Herrmann and Johannes Czernin
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1821-1823; DOI: https://doi.org/10.2967/jnumed.124.268904

The State of the Art

  • You have access
    Modeling PET Data Acquired During Nonsteady Conditions: What If Brain Conditions Change During the Scan?
    Evan D. Morris, Gaelle M. Emvalomenos, Jocelyn Hoye and Steven R. Meikle
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1824-1837; DOI: https://doi.org/10.2967/jnumed.124.267494

Continuing Education

  • Open Access
    Precision Oncology in Melanoma: Changing Practices
    Sean C. Dougherty, William L. Flowers and Elizabeth M. Gaughan
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1838-1845; DOI: https://doi.org/10.2967/jnumed.124.267781

Is It Really Happening?

  • You have access
    The Translation of Dosimetry into Clinical Practice: What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice
    Manuel Bardiès, Glenn Flux and Katarina Sjögreen Gleisner
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1846-1847; DOI: https://doi.org/10.2967/jnumed.124.267742

Editorials

  • Open Access
    Feasibility of 177Lu-PSMA Administration as Outpatient Procedure for Prostate Cancer
    Federico Zagni, Luigia Vetrone, Andrea Farolfi, Maria Vadalà, Elisa Lodi Rizzini, Arber Golemi, Lidia Strigari and Stefano Fanti
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1848-1849; DOI: https://doi.org/10.2967/jnumed.124.268062
    • INVITED PERSPECTIVE

      • You have access
        Changed Regulation Enables Pragmatic Solution for Cancer Patients
        Uwe Holzwarth
        Journal of Nuclear Medicine December 1, 2024, 65 (12) 1850; DOI: https://doi.org/10.2967/jnumed.124.268945
      • You have access
        Challenges with 177Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice
        Hossein Jadvar, Amir Iravani, Lisa Bodei and Jeremie Calais
        Journal of Nuclear Medicine December 1, 2024, 65 (12) 1851-1854; DOI: https://doi.org/10.2967/jnumed.124.268023

Oncology

  • Clinical

    • Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial
      You have access
      Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial
      Kai Jannusch, Lale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, Janna Morawitz, Ken Herrmann, Wolfgang Peter Fendler, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, Martin Stuschke, Werner Schmid, Frederik Giesel, Lena Häberle, Irene Esposito, Wilfried Budach, Johannes Grueneisen, Christiane Matuschek, Bernd Kowall, Andreas Stang, Gerald Antoch and Christian Buchbender
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1855-1861; DOI: https://doi.org/10.2967/jnumed.124.268065
    • Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate–Ribose) Polymerase-1–Targeted <sup>18</sup>F-Fluorthanatrace PET in Breast Cancer
      You have access
      Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate–Ribose) Polymerase-1–Targeted 18F-Fluorthanatrace PET in Breast Cancer
      Anthony J. Young, Austin R. Pantel, Mahsa Kiani, Robert K. Doot, Sina Bagheri, Daniel A. Pryma, Michael D. Farwell, Shihong Li, Hsiaoju Lee, Erin K. Schubert, Anthony Secreto, Samantha P. Zuckerman, Anupma Nayak, Hoon Choi, Sean Carlin, Angela DeMichele, David A. Mankoff, Rong Zhou, Robert H. Mach and Elizabeth S. McDonald
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1862-1868; DOI: https://doi.org/10.2967/jnumed.124.268254
    • [<sup>18</sup>F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
      You have access
      [18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
      Jelena Levi, Millie Das, Minal S. Vasanawala, Deepti Behl, Martin Pomper, Patrick M. Forde, Erica Nakajima, James Sayre, Bin Shen, Hilda Cabrera, Niko Del Mar, Michele Gullen, Michele Pierini, Laura Cox, Ojaswita Lokre, Timothy Perk and Hee-Don Chae
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1869-1875; DOI: https://doi.org/10.2967/jnumed.124.268253
    • International Metabolic Prognostic Index Is Superior to Other Metabolic Tumor Volume–Based Prognostication Methods in a Real-Life Cohort of Diffuse Large B-Cell Lymphoma
      You have access
      International Metabolic Prognostic Index Is Superior to Other Metabolic Tumor Volume–Based Prognostication Methods in a Real-Life Cohort of Diffuse Large B-Cell Lymphoma
      Vibeke K.J. Vergote, Gregor Verhoef, Ann Janssens, F.J. Sherida H. Woei-a-jin, Wies Deckers, Annouschka Laenen, Thomas Tousseyn, Daan Dierickx and Christophe M. Deroose
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1876-1883; DOI: https://doi.org/10.2967/jnumed.124.268152
    • Value of [<sup>68</sup>Ga]Ga-NYM046 PET/CT, in Comparison with <sup>18</sup>F-FDG PET/CT, for Diagnosis of Clear Cell Renal Cell Carcinoma
      Open Access
      Value of [68Ga]Ga-NYM046 PET/CT, in Comparison with 18F-FDG PET/CT, for Diagnosis of Clear Cell Renal Cell Carcinoma
      Kequan Lou, Jialiang Wang, Huihui He, Yanjuan Wang, Yuanyuan Mi, Wenjin Li, Liping Chen, Yu Zhang, Yong Mao, Jianguo Lin, Haitian Fu and Chunjing Yu
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1884-1890; DOI: https://doi.org/10.2967/jnumed.124.267527
    • CD70-Targeted Immuno-PET/CT Imaging of Clear Cell Renal Cell Carcinoma: A Translational Study
      You have access
      CD70-Targeted Immuno-PET/CT Imaging of Clear Cell Renal Cell Carcinoma: A Translational Study
      Xiang Zhou, Qianyun Wu, Wei Zhai, You Zhang, Yanfei Wu, Min Cao, Cheng Wang, Yihui Guan, Jianjun Liu, Fang Xie and Weijun Wei
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1891-1898; DOI: https://doi.org/10.2967/jnumed.124.268509
    • [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-04–Directed Imaging for Outcome Prediction in Patients with High-Grade Neuroendocrine Neoplasms
      Open Access
      [18F]FDG and [68Ga]Ga-FAPI-04–Directed Imaging for Outcome Prediction in Patients with High-Grade Neuroendocrine Neoplasms
      Kerstin Michalski, Aleksander Kosmala, Philipp E. Hartrampf, Marieke Heinrich, Sebastian E. Serfling, Wiebke Schlötelburg, Andreas K. Buck, Alexander Meining, Rudolf A. Werner and Alexander Weich
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1899-1903; DOI: https://doi.org/10.2967/jnumed.124.268288
  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Immuno-PET/CT Imaging of Trop2 with [<sup>18</sup>F]AlF-RESCA-T4 Differentiates Lung Cancer from Inflammation
        You have access
        Immuno-PET/CT Imaging of Trop2 with [18F]AlF-RESCA-T4 Differentiates Lung Cancer from Inflammation
        Wei Huang, Min Cao, Yanfei Wu, You Zhang, Shuxian An, Xinbing Pan, Xinyuan Zhou, Hongda Shao, Yihui Guan, Gang Huang, Fabrizia Gelardi, Arturo Chiti, Fang Xie, Jianjun Liu and Weijun Wei
        Journal of Nuclear Medicine December 1, 2024, 65 (12) 1904-1910; DOI: https://doi.org/10.2967/jnumed.124.268751

Theranostics

  • Clinical

    • FEATURED ARTICLE OF THE MONTH

      • Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
        You have access
        Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
        Adriana Amerein, Christoph Maurer, Malte Kircher, Alexander Gäble, Anne Krebold, Andreas Rinscheid, Oliver Viering, Christian H. Pfob, Ralph A. Bundschuh, Lars Behrens, Arthur JAT Braat, Ansgar Berlis and Constantin Lapa
        Journal of Nuclear Medicine December 1, 2024, 65 (12) 1911-1916; DOI: https://doi.org/10.2967/jnumed.124.268217
    • Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with <sup>213</sup>Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors
      You have access
      Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors
      Andreas Helisch, Clemens Kratochwil, Christian Kleist, Susanne Krämer, Juan Jose Rosales Castillo, Katharina Dendl, Hendrik Rathke, Isabelle von Goetze, Mathias Schreckenberger, Dirk Jäger, Thomas Lindner, Walter Mier, Frederik Giesel, Uwe Haberkorn and Manuel Röhrich
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1917-1922; DOI: https://doi.org/10.2967/jnumed.124.268386
    • Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI
      You have access
      Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI
      Ida Sonni, Adam B. Weiner, Sahith Doddipalli, Madhvi Deol, David Ban, Hye Ok Kim, Tristan Grogan, Preeti Ahuja, Nashla Barroso, Yang Zong, Priti Soin, Anthony Sisk, Johannes Czernin, William Hsu, Jeremie Calais, Robert E. Reiter and Steven S. Raman
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1923-1931; DOI: https://doi.org/10.2967/jnumed.124.268443
    • Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [<sup>177</sup>Lu]Lu-PSMA-617
      You have access
      Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [177Lu]Lu-PSMA-617
      Miguel Muniz, Oliver Sartor, Jacob J. Orme, Regina M. Koch, Hana R. Rosenow, Ahmed M. Mahmoud, Jack R. Andrews, Adam M. Kase, Irbaz B. Riaz, Gokce Belge Bilgin, Matthew P. Thorpe, A. Tuba Kendi, Geoffrey B. Johnson, Praful Ravi, Eugene D. Kwon and Daniel S. Childs
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1932-1938; DOI: https://doi.org/10.2967/jnumed.124.268277
    • Comparison of Posttherapy 4- and 24-Hour [<sup>177</sup>Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer
      You have access
      Comparison of Posttherapy 4- and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer
      Mina Swiha, Sarennya Pathmanandavel, Nathan Papa, Zahra Sabahi, Sherrington Li, Alex Zheng, Sobia Khan, Maria Ayers, Shikha Sharma, Megan Crumbaker, Andrew Nguyen, Lyn Chan, Narjess Ayati and Louise Emmett
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1939-1944; DOI: https://doi.org/10.2967/jnumed.124.267606
    • SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving <sup>177</sup>Lu-PSMA-617
      You have access
      SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617
      Ridvan Arda Demirci, Roman Gulati, Jessica E. Hawley, Todd Yezefski, Michael C. Haffner, Heather H. Cheng, Robert B. Montgomery, Michael T. Schweizer, Evan Y. Yu, Peter S. Nelson, Delphine L. Chen and Amir Iravani
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1945-1951; DOI: https://doi.org/10.2967/jnumed.124.267665
    • FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study
      You have access
      FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study
      Rong Rong Huang, Chunlai Zuo, Christine E. Mona, Adrien Holzgreve, Colm Morrissey, Peter S. Nelson, Lauren Brady, Lawrence True, Anthony Sisk, Johannes Czernin, Jeremie Calais and Huihui Ye
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1952-1958; DOI: https://doi.org/10.2967/jnumed.124.268037

Endocrinology

  • Clinical

    • Improved Localization of Insulinomas Using <sup>68</sup>Ga-NODAGA-Exendin-4 PET/CT
      Open Access
      Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT
      Marti Boss, Olof Eriksson, Kirsi Mikkola, Annemarie Eek, Maarten Brom, Mijke Buitinga, Adrienne H. Brouwers, Irina Velikyan, Beatrice Waser, Saila Kauhanen, Olof Solin, Camille Marciniak, Barbro Eriksson, Jean-Claude Reubi, Cyrielle Aveline, Damian Wild, Francois Pattou, Jean-Noel Talbot, Johannes Hofland, Anders Sundin, Pirjo Nuutila, John Hermans and Martin Gotthardt
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1959-1964; DOI: https://doi.org/10.2967/jnumed.124.268158

Radiochemistry

  • Basic

    • SPECIAL CONTRIBUTION

      • MIRD Pamphlet No. 31: MIRDcell V4—Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy
        You have access
        MIRD Pamphlet No. 31: MIRDcell V4—Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy
        Sumudu Katugampola, Jianchao Wang and Roger W. Howell
        Journal of Nuclear Medicine December 1, 2024, 65 (12) 1965-1973; DOI: https://doi.org/10.2967/jnumed.123.267238

Physics and Instrumentation

  • Basic

    • Performance Characteristics of a New Generation 148-cm Axial Field-of-View uMI Panorama GS PET/CT System with Extended NEMA NU 2-2018 and EARL Standards
      Open Access
      Performance Characteristics of a New Generation 148-cm Axial Field-of-View uMI Panorama GS PET/CT System with Extended NEMA NU 2-2018 and EARL Standards
      Haiqiong Zhang, Chao Ren, Yu Liu, Xinchun Yan, Meixi Liu, Zhixin Hao, Haiqun Xing and Li Huo
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1974-1982; DOI: https://doi.org/10.2967/jnumed.124.267963

The Illustrated Post

  • You have access
    CT Enhancement of a Nasal Leech After Thrombectomy
    Kaiwu Meng and Dian He
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1983; DOI: https://doi.org/10.2967/jnumed.124.268796

Letters to the Editor

  • You have access
    One Bite from the Apple, One Bite from the Orange in the PRECISE-MDT Study
    Andrei Fodor, Cristiano Pini, Gaia Ninatti, Nadia Di Muzio and Arturo Chiti
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1984; DOI: https://doi.org/10.2967/jnumed.124.268395
  • You have access
    Limitations of Retrospective Study Design and Potential Bias in the PRECISE-MDT Study
    Tadashi Watabe
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1985; DOI: https://doi.org/10.2967/jnumed.124.268447
  • You have access
    Reply: One Bite from the Apple, One Bite from the Orange in the PRECISE-MDT Study and Limitations of Retrospective Study Design and Potential Bias in the PRECISE-MDT Study
    Matteo Bauckneht, Francesco Lanfranchi and Liliana Belgioia
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1986; DOI: https://doi.org/10.2967/jnumed.124.268781

Departments

  • You have access
    A Banner Year for Nuclear Medicine, Molecular Imaging, and Theranostics
    Cathy Sue Cutler
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 7A-8A; DOI: https://doi.org/10.2967/jnumed.6512PresMessage
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 65 (12)
Journal of Nuclear Medicine
Vol. 65, Issue 12
December 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
  • Immuno-PET/CT Imaging of Trop2 with [18F]AlF-RESCA-T4 Differentiates Lung Cancer from Inflammation
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Continuing Education
  • Is It Really Happening?
  • Editorials
  • INVITED PERSPECTIVE
  • Oncology
    • Clinical
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Theranostics
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
  • Endocrinology
    • Clinical
  • Radiochemistry
    • Basic
      • SPECIAL CONTRIBUTION
  • Physics and Instrumentation
    • Basic
  • The Illustrated Post
  • Letters to the Editor
  • Departments
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire